X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (6) 6
humans (6) 6
index medicus (5) 5
male (5) 5
middle aged (5) 5
adult (4) 4
analysis (3) 3
aged (2) 2
aged, 80 and over (2) 2
basal cell carcinoma (2) 2
biphenyl compounds - administration & dosage (2) 2
biphenyl compounds - adverse effects (2) 2
carcinoma, basal cell - drug therapy (2) 2
care and treatment (2) 2
double-blind method (2) 2
drug therapy (2) 2
metastasis (2) 2
open-label (2) 2
pyridines - administration & dosage (2) 2
pyridines - adverse effects (2) 2
rheumatology (2) 2
skin (2) 2
skin neoplasms - drug therapy (2) 2
skin neoplasms - pathology (2) 2
vismodegib (2) 2
young adult (2) 2
1304 (1) 1
1313 (1) 1
1316 (1) 1
1523 (1) 1
1560 (1) 1
31–50 years (1) 1
334 (1) 1
532 (1) 1
541 (1) 1
610 medicine & health (1) 1
adamantinoma - diagnosis (1) 1
adamantinoma - surgery (1) 1
advanced basal cell carcinoma (1) 1
advanced solid tumors (1) 1
africa (1) 1
angiogenesis (1) 1
angiogenesis inhibitors (1) 1
antikeratin antibodies (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents - therapeutic use (1) 1
area under curve (1) 1
arthritis, rheumatoid - diagnosis (1) 1
arthritis, rheumatoid - metabolism (1) 1
article (1) 1
association (1) 1
autoantibodies - blood (1) 1
autoimmunity (1) 1
basal cell carcinoma outcomes with lde225 treatment study (1) 1
biphenyl compounds (1) 1
biphenyl compounds - therapeutic use (1) 1
cancer (1) 1
cancer-therapy (1) 1
carcinoma, basal cell (1) 1
carcinoma, basal cell - pathology (1) 1
carcinoma, basal cell - radiotherapy (1) 1
carcinoma, basal cell - secondary (1) 1
carcinoma, basal cell - surgery (1) 1
cell cycle (1) 1
citrullination (1) 1
citrulline - metabolism (1) 1
clinical trials (1) 1
corn (1) 1
dermatology (1) 1
dermatology clinic (1) 1
diagnosis (1) 1
disease progression (1) 1
disease-free survival (1) 1
dosage and administration (1) 1
dose-escalation (1) 1
drug dosages (1) 1
dyspnea - etiology (1) 1
efficacy (1) 1
enzyme-linked immunosorbent assay (1) 1
enzymes (1) 1
eosinophilia - etiology (1) 1
eosinophilic fasciitis (1) 1
european-organization (1) 1
everolimus (1) 1
fasciitis - etiology (1) 1
fatal outcome (1) 1
fibrin (1) 1
fibula (1) 1
fluid (1) 1
glucocorticoids - administration & dosage (1) 1
glucocorticoids - therapeutic use (1) 1
guidelines (1) 1
healthy subjects (1) 1
hedgehog pathway (1) 1
hedgehog pathway inhibitor (1) 1
hedgehog-pathway (1) 1
hematology, oncology and palliative medicine (1) 1
hemoptysis - etiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 6, pp. 716 - 728
Journal Article
Journal of the American Academy of Dermatology, ISSN 0190-9622, 2016, Volume 75, Issue 1, pp. 113 - 125.e5
Background The hedgehog pathway inhibitor sonidegib demonstrated meaningful tumor shrinkage in more than 90% of patients with locally advanced basal cell... 
Dermatology | Basal Cell Carcinoma Outcomes with LDE225 Treatment study | hedgehog pathway inhibitor | sonidegib | locally advanced basal cell carcinoma | metastatic basal cell carcinoma | advanced basal cell carcinoma | Locally advanced basal cell carcinoma | Advanced basal cell carcinoma | Metastatic basal cell carcinoma | Sonidegib | Hedgehog pathway inhibitor | HEDGEHOG PATHWAY | MULTICENTER | VISMODEGIB | MANAGEMENT | EFFICACY | GUIDELINES | OPEN-LABEL | DERMATOLOGY | DOSE-ESCALATION | UPDATE | INHIBITOR | Skin Neoplasms - drug therapy | Humans | Middle Aged | Carcinoma, Basal Cell - secondary | Biphenyl Compounds - adverse effects | Male | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Biphenyl Compounds - therapeutic use | Young Adult | Pyridines - adverse effects | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Smoothened Receptor - antagonists & inhibitors | Pyridines - therapeutic use | Skin Neoplasms - pathology | Pyridines - administration & dosage | Double-Blind Method | Survival Rate | Disease Progression | Biphenyl Compounds - administration & dosage | Carcinoma, Basal Cell - drug therapy | Aged | Medical research | Care and treatment | Basal cell carcinoma | Analysis | Patient outcomes | Corn | Medicine, Experimental | Skin | Metastasis | Drug therapy | Cancer
Journal Article
BMJ case reports, ISSN 1757-790X, 2011, Volume 2011, Issue oct16 1, pp. bcr0620114318 - bcr0620114318
Adamantinoma is a rare tumour of long bones, representing less than 1% of them. Adamantinoma commonly occurs in the tibia. It is locally aggressive and... 
Lung Neoplasms - drug therapy | Fibula | Humans | Middle Aged | Dyspnea - etiology | Lung Neoplasms - complications | Adamantinoma - surgery | Lung Neoplasms - secondary | Tibia | Adamantinoma - diagnosis | Fatal Outcome | Female | Hemoptysis - etiology
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.